A reanalysis of whole-genome data from 130 children conceived after the Chernobyl disaster has identified a statistically ...

Increasingly low vaccination rates, more summer indoor gatherings and a new mutation of a highly infectious strain are ...

Patients with stage 4 lung cancer and EGFR mutations may benefit from combination therapies that improve disease control. The American Society of Clinical Oncology (ASCO) released updated treatment ...

A recent study shows that people with the highest intake of ultraprocessed foods had a 48% higher rate of death from any cause and a 57% higher rate of death from cancer.

In an advance for precision oncology, the largest published study to date on molecular residual disease (MRD) detection in stage 3 colon cancer has demonstrated the prognostic capabilities of Guardant ...

NSCLC remains the leading cause of cancer-related mortality worldwide, with EGFR mutations being a critical driver in approximately 10-15% of lung adenocarcinomas in Western populations, and up to 40% ...

Researchers have uncovered the enzyme behind chromothripsis, a chaotic chromosome-shattering event seen in about one in four ...

Results showed the combination reduced the risk of death by 24% compared with chemotherapy alone, extending median OS to 18.2 ...

EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight ...

PORTSMOUTH, Va. (WAVY) — The 2025-2026 flu season has been one of the worst in recent history. According to CDC data, during the last week of 2025, the influenza-associated hospitalization rate peaked ...

Many areas of California are experiencing high levels of flu activity, especially amongst children, according to health ...